Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
Tags :Frank Gerhard
DKSH Holding has announced the acquisition of Swiss Refarmed Group, strengthening its capabilities in the life sciences. Through the acquisition, DKSH Business Unit Performance Materials, the leading global distributor of innovative pharmaceutical ingredients synthesis and
Clariant has completed the sale of its pigments business to a consortium of Heubach Group and SK Capital Partners and reinvested approx. CHF 115 million of the purchase price to become a 20% shareholder alongside Heubach Group
Allosteric modulation company Addex Therapeutics has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares («ADSs») at
Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Private equity healthcare fund ArchiMed announced the acquisition of Stragen Pharma from its founder and several shareholders, through its EUR 1 billion MED Platform I fund. The advisors Walder Wyss acted as legal counsel
Private equity firm, Naxicap Partners has closed the acquisition of a majority stake in Groupe 3R (Réseau Radiologique Romand), a Swiss radiological network created by Dr. Dominique Fournier. The advisors Python advised Naxicap Partners
The Heubach Group, in partnership with Sk Capital, announced today a definitive agreement to acquire Clariant’s pigments business. The combined business will operate under the Heubach name, creating a global pigments leader generating more
PolyPeptide Group AG, a global operator in peptide development and manufacturing, successfully priced its initial public offering (IPO) at CHF 64 per share, implying a market capitalization of CHF 2.12 bn. The base offering of the IPO
Dufry One launched successfully completed the issuance of CHF 300 m 3.625% Senior Notes due 2026 and EUR 725 m 3.375% Senior Notes due 2028. The Senior Notes are guaranteed by Dufry and certain of its subsidiaries. It is expected that
